ABVC BioPharma, Inc.
ABVC
$1.23
-$0.08-6.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 745.80K | 257.20K | 453.50K | 217.30K | 313.10K |
| Total Receivables | 763.40K | 2.69M | 1.42M | 537.10K | 1.16M |
| Inventory | -- | 11.50K | 11.50K | 11.50K | -- |
| Prepaid Expenses | 346.60K | 447.30K | 195.00K | 96.40K | 96.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 645.50K | 661.80K | 688.10K | 607.40K | 615.40K |
| Total Current Assets | 2.50M | 4.07M | 2.77M | 1.47M | 2.18M |
|
|
|||||
| Total Current Assets | 2.50M | 4.07M | 2.77M | 1.47M | 2.18M |
| Net Property, Plant & Equipment | 14.75M | 12.42M | 8.67M | 8.70M | 1.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.93M | 1.93M | 1.96M | 1.94M | 1.95M |
| Total Assets | 21.06M | 21.18M | 16.24M | 14.88M | 7.54M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.20M | 3.04M | 3.10M | 3.00M | 2.95M |
| Short-term Debt | 755.80K | 1.74M | 1.30M | 1.37M | 1.46M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.12M | 571.00K | 695.30K | 1.34M | 1.50M |
| Total Finance Division Other Current Liabilities | 1.09M | 1.16M | 1.44M | 1.02M | 647.50K |
| Total Other Current Liabilities | 1.09M | 1.16M | 1.44M | 1.02M | 647.50K |
| Total Current Liabilities | 6.16M | 6.51M | 6.53M | 6.73M | 6.56M |
|
|
|||||
| Total Current Liabilities | 6.16M | 6.51M | 6.53M | 6.73M | 6.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 755.80K | 1.74M | 1.30M | 1.37M | 1.46M |
| Capital Leases | 1.60M | 164.10K | 177.10K | 167.00K | 236.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 12.00K | 41.70K | 21.70K | 21.70K |
| Total Liabilities | 7.76M | 6.68M | 6.75M | 6.92M | 6.82M |
|
|
|||||
| Common Stock & APIC | 96.03M | 93.14M | 86.40M | 83.63M | 78.61M |
| Retained Earnings | -76.86M | -73.30M | -72.05M | -69.79M | -68.95M |
| Treasury Stock & Other | -8.06M | -7.79M | -7.34M | -8.43M | -8.43M |
| Total Common Equity | 11.11M | 12.06M | 7.01M | 5.40M | 1.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.11M | 12.06M | 7.01M | 5.40M | 1.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.19M | 2.44M | 2.48M | 2.55M | -502.20K |
| Total Equity | 13.30M | 14.49M | 9.49M | 7.96M | 724.00K |
|
|
|||||